Comments on “Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trials”
Therapeutic Advances in Cardiovascular Disease · 2026-05 · 20
DOI: 10.1177/17539447261453501 ↗Kurz gefasst
Leserbrief in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, online erschienen am 21.05.2026. Verfasst von Ankur Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, School of Medical Sciences and Research, Sharda University, Greater Noida, India. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Anatomy, School of Medical Sciences and Research, Sharda University, Greater Noida, India.
- Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed-to-be-University), Pimpri, Pune, Pimpri-Chinchwad, Maharashtra, India.
- Faculty of Pharmaceutical Sciences, Graphic Era Hill University, Dehradun, India.
- Centre for Promotion of Research, Graphic Era Deemed University, Dehradun, India.
- Department of Pharmaceutics, Noida Institute of Engineering & Technology (Pharmacy Institute), Greater Noida, India.
- Department of Community Medicine, Malla Reddy Institute of Medical Sciences, Malla Reddy Vishwavidyapeeth, Suraram, Hyderabad 500055, Telangana, India.
ORCID-Profile: Sushma Narsing Katkuri
Zitieren
APA
Sharma, A., Vadhithala, V., Kumar, A., Verma, S., & Katkuri, S. N. (2026). Comments on “Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trials”. Therapeutic Advances in Cardiovascular Disease, 20. https://doi.org/10.1177/17539447261453501
Vancouver
Sharma A, Vadhithala V, Kumar A, Verma S, Katkuri SN. Comments on “Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trials”. Therapeutic Advances in Cardiovascular Disease. 2026;20. doi:10.1177/17539447261453501
BibTeX
@article{Sharma2026,
author = {Sharma, Ankur and Vadhithala, Varshini and Kumar, Arun and Verma, Sushma and Katkuri, Sushma Narsing},
title = {Comments on “Neurological efficacy and safety of RNA therapeutics in hereditary transthyretin amyloidosis: a systematic review and meta-analysis of randomized controlled trials”},
journal = {Therapeutic Advances in Cardiovascular Disease},
year = {2026},
volume = {20},
doi = {10.1177/17539447261453501}
}
EUVIMED